Compare LYEL & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LYEL | BMRC |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.8M | 424.3M |
| IPO Year | 2021 | N/A |
| Metric | LYEL | BMRC |
|---|---|---|
| Price | $25.77 | $27.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $25.00 | ★ $28.00 |
| AVG Volume (30 Days) | 92.1K | ★ 106.6K |
| Earning Date | 03-10-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $41,000.00 | ★ $33,022,000.00 |
| Revenue This Year | N/A | $291.71 |
| Revenue Next Year | N/A | $7.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.65 | $19.14 |
| 52 Week High | $45.00 | $28.48 |
| Indicator | LYEL | BMRC |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | 53.57 |
| Support Level | $23.00 | $26.04 |
| Resistance Level | $26.02 | $27.13 |
| Average True Range (ATR) | 1.75 | 1.06 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 61.48 | 58.78 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties and others. The majority of its revenue comes from interest income.